1.Construction of Laboratory Animal Science and Technology Ethics Governance System in China and Its Preliminary Practice in Guangdong Province
Xiaoqin LI ; Wenlan YU ; Yizhu DUAN ; Zhonghua LIU ; Guodong WU ; Wenqi SHI ; Hongkun FU
Laboratory Animal and Comparative Medicine 2026;46(1):127-137
The welfare and ethics of laboratory animals are the ethical principles and behavioral norms that need to be followed in conducting animal-based scientific research, breeding and managing laboratory animals, and supervising and regulating such activities. The level of protection of laboratory animal welfare and ethics is closely related to the development of science and technology, which has become a widely recognized international consensus. At present, Guangdong Province is accelerating the construction of a high-level science and technology innovation province and the Guangdong-Hong Kong-Macao Greater Bay Area International Science and Technology Innovation Center. Guangdong Province should rely on its advanced governance capacity in the field of laboratory animal science and technology ethics to promote the high-quality development of its laboratory animal science and technology sector. Based on the management laws, regulations, and institutional mechanisms of laboratory animals in China, this paper explores the optimization of the laboratory animal science and technology ethics governance system, which includes the institutional guarantees, responsibility systems, ethical review and supervision mechanisms, and education and outreach. Through methods such as literature research, questionnaire surveys, and interview investigations, an empirical study of the laboratory animal science and technology ethics governance system in Guangdong Province has been conducted. Analysis of literature and research results shows that Guangdong Province has basically established a laboratory animal management system, collaboration mechanism, supervision mechanism, and education and training system that meet the current requirements of the laboratory animal science and technology ethics governance system in China. However, there are still problems such as an incomplete laboratory animal science and technology ethics supervision mechanism, an underdeveloped operation mechanism of review institutions, insufficient attention paid by laboratory animal units to the ethical review of animal experiments, inconsistent ethical review standards, and a lack of professional ethical education and training for ethics review personnel. Therefore, optimization measures such as improving the laboratory animal science and technology ethics review system, strengthening supervision and inspection, further strengthening the accountability of responsible entities, formulating review norms, and enhancing hierarchical and classified education and training are proposed, to provide a theoretical basis for promoting the normalized and long-term governance of laboratory animal science and technology ethics in Guangdong Province.
2.Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review
Shuxuan QIU ; Lin GUO ; Ruiying WANG ; Xudong MA ; Mingsan MIAO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(9):276-283
Hepatic fibrosis (HF) is an abnormal repair process that occurs after chronic liver injury. It is characterized by excessive accumulation of extracellular matrix in the liver, resulting in fibrous tissue hyperplasia, which may further develop into cirrhosis and even liver cancer. Currently, there is a lack of specific anti-HF drugs in clinical practice. Traditional Chinese medicine (TCM) has advantages in the treatment of HF, including multi-component and multi-target interventions with high safety, and can significantly delay the progression of HF. It has therefore become a current research hotspot. Nuclear factor erythroid 2-related factor 2 (Nrf2), as a key transcription factor involved in antioxidant stress, can effectively intervene in the progression of HF by activating the expression of downstream antioxidant enzymes and detoxification genes. This article systematically reviews the mechanisms by which active components of Chinese medicine (such as flavonoids, polysaccharides, and saponins) and TCM compound prescriptions (such as Haobie Yangyin Ruanjian prescription and Biejia Xiaozheng pills) exert anti-fibrotic effects through activation of the Nrf2 signaling pathway, including enhancing antioxidant capacity, inhibiting inflammatory responses, reducing hepatocyte apoptosis, improving mitochondrial function, and inhibiting the ferroptosis pathway. In addition, this article points out the current shortcomings in research based on the Nrf2 signaling pathway and proposes corresponding suggestions to promote related studies. It also provides an important theoretical basis for the development of novel anti-HF Chinese medicine targeting Nrf2.
3.Study on the mechanism of Huatan qushi huoxue formula in improving metabolic dysfunction-associated steatohepatitis by inhibiting macrophage pyroptosis
Yajie GUAN ; Qizhen ZHANG ; Junjiao XU ; Yijia SONG ; Dongfang SHANG ; Wenxia ZHAO ; Minghao LIU
China Pharmacy 2026;37(7):864-869
OBJECTIVE To focus on the classic NOD-like receptor protein 3 (NLRP3)/Caspase-1/gasdermin D (GSDMD) pyroptosis pathway and explore the mechanism by which Huatan qushi huoxue formula (HQHF) inhibits macrophage pyroptosis to ameliorate metabolic dysfunction-associated steatohepatitis (MASH). METHODS RAW264.7 cells were divided into 5 groups: Control group (10% blank serum), Model group [10% blank serum+5 μg/mL lipopolysaccharide (LPS)], HQHF-L group (2.5% drug-containing serum+7.5% blank serum+5 μg/mL LPS), HQHF-M group (5% drug-containing serum+5% blank serum+5 μg/mL LPS), and HQHF-H group (10% drug-containing serum+5 μg/mL LPS). After 24 h of routine culture post-administration, cells and supernatants were collected for assays. Cell morphology was observed via scanning electron microscopy and phase-contrast microscopy; localization and expression of gasdermin D-N (GSDMD-N) were observed by immunofluorescence. Interleukin-1β (IL-1β) and IL-18 contents in supernatants were detected by ELISA; mRNA and protein expressions of NLRP3, Caspase-1, and GSDMD were measured using real-time PCR and Western blot. RESULTS Compared with the Control group, the Model group showed typical pyroptotic morphology (cell membrane bulging and pore formation), increased aggregation and fluorescence intensity of GSDMD-N on the cell membrane ( P <0.05), significantly increased the contents of IL-1β and IL-18 in cell supernatants ( P <0.05), and significantly up-regulated mRNA and protein expressions of NLRP3, Caspase-1, and GSDMD in cells ( P <0.05). Compared with the Model group, the HQHF-L, HQHF-M and HQHF-H groups showed improved pyroptotic morphology, reduced membrane localization and significantly weakened fluorescence intensity of GSDMD-N ( P <0.05), significantly decreased the contents of IL-1β and IL-18 in cell supernatants ( P <0.05), and significantly down-regulated mRNA and protein expressions of NLRP3, Caspase-1, and GSDMD in cells ( P <0.05). CONCLUSIONS HQHF inhibits LPS-induced macrophage pyroptosis, and its mechanism of improving MASH may be associated with the suppression of the activation of the classical NLRP3/Caspase-1/GSDMD pyroptosis pathway.
4.Evaluation of the effectiveness of acupoint catgut embedding for obesity
Bai Caixia ; Oyunbileg Yu ; Tsend-Ayush D
Mongolian Journal of Health Sciences 2026;91(1):124-128
Background:
Obesity is defined as a condition in which excessive fat accumulates in subcutaneous adipose tissue and other tissues due to metabolic disorders, leading to an increase in body weight. As of 2006, 31.6% of the Mongolian population aged 15–64 years were overweight or obese, of whom 21.8% were overweight and 9.8% were obese. By 2019, this proportion had increased to 49.4% being overweight or obese, including 30.9% overweight and 18.5% obese. These figures indicate that the Mongolian population has become affected by the obesity epidemic. Therefore, this study was conducted with the aim of scientifically validating the effectiveness of acupoint catgut embedding for obesity through a clinical experimental research approach.
Aim:
To evaluate the effectiveness of acupoint catgut embedding in patients with obesity.
Materials and Methods:
This study was conducted as a clinical experimental research using a descriptive study design at the Mongolian National University of Medical Sciences (MNUMS) International School of Mongolian Medicine, the Central Hospital of Mongolian Medicine and the Second Traditional Chinese and Mongolian Hospital of Chifeng city, Inner Mongolia Autonomous Region, PRC, from July 2025 to January 2026. A total of 76 adult participants were enrolled based on the following inclusion criteria: If the participant is female, she must have regular menstrual cycles, confirmed diagnosis of obesity (BMI ≥25 kg/m², or waist circumference >94 cm for men and >80 cm for women, or waist-to-hip ratio >0.95 for men and >0.85 for women), and willingness to participate voluntarily. Participants received catgut embedding at acupoints Zhongwan (CV12), Xiawan (CV10), Guanyuan (CV4), Qihai (CV6), Daimai (GB26), Daheng (SP15), Tianshu (ST25) and Huaroumen (ST24) once every 14 days for a total of two sessions. The effectiveness of the intervention was assessed by comparing body weight, BMI, body fat percentage, waist and hip circumference, selected metabolic parameters (GLU, HDL, LDL, CHOL, TG), and depression scores (Beck Depression Inventory) before treatment and 30 days after the intervention.
Result:
After acupoint catgut embedding, participants showed statistically significant reductions in body weight, BMI, body fat percentage, waist circumference, and hip circumference (p=0.0001). HDL increased from 1.62 ± 14.77 mmol/L to 1.80 ± 0.64 mmol/L and LDL increased from 2.21 ± 0.55 mmol/L to 2.57 ± 0.84 mmol/L, both showing statistically significant increases (p=0.0001). Total cholesterol increased slightly from 4.36 ± 0.88 mmol/L to 4.43 ± 0.8 mmol/L, but this change was not statistically significant (p=0.24). Triglycerides decreased from 1.45 ± 0.68 mmol/L to 1.30 ± 0.62 mmol/L, representing a statistically significant improvement (p=0.005). Fasting glucose increased from 4.17 ± 0.66 mmol/L to 4.66 ± 0.62 mmol/L (p=0.0001). Depression assessment showed that before the study, 17 participants (22.4%) had no depression, 19 (25.0%) had mild depression, 12 (15.8%) had moderate depression, and 28 (36.8%) had severe depression. After treatment, 36 participants (47.4%) had no depression, 20 (26.3%) had mild depression, 8 (10.5%) had moderate depression, and 12 (15.8%) had severe depression.
Conclusion
1. Acupoint catgut embedding for obesity reduces body weight, BMI, body fat percentage, waist circumference and hip circumference.
2. Acupoint catgut embedding increases HDL-C, LDL-C and fasting glucose levels and decreases triglyceride levels.
3. Acupoint catgut embedding reduces the severity of depression.
5.Effect of Traditional Medicine and Acupuncture Therapy on Postoperative Ileus Following Adhesive Small Bowel Obstruction
Undarmaa B ; Nasanhishig D ; Oyun-Erdene U ; Tserendulam G ; Anudari M ; Alzakhgui M ; Oyunbileg Yu ; Batchimeg N ; Enkhtuya V
Mongolian Journal of Health Sciences 2026;93(3):221-226
Background:
Adhesion small bowel obstruction (ASBO) is a common complication following abdominal surgery and can significantly impair postoperative recovery. This condition necessitates the exploration of more effective therapeutic approaches.
Aim:
The aim of this study was to evaluate the clinical efficacy of Traditional Mongolian Medicine (TMM) combined with acupuncture in the management of postoperative ileus secondary to adhesion-related small bowel obstruction.
Case Presentation:
We report the case of a 47-year-old female patient who developed postoperative ileus. The therapeutic intervention consisted of a combined regimen of traditional herbal pharmacotherapy and electroacupuncture. The clinical outcomes were assessed based on the resolution of symptoms and the restoration of gastrointestinal function.
Result:
Following the administration of the integrated treatment, the patient exhibited a marked reduction in abdominal pain. Objective clinical improvement was noted through the successful restoration of intestinal peristalsis and the normalization of flatus and defecation.
Conclusion
The findings of this case study suggest that Traditional Mongolian Medicine, particularly when integrated with electroacupuncture, may be an effective and viable modality for promoting the recovery of gastrointestinal motility in patients with adhesion-related small bowel obstruction.
6.Treatment of miniere’s disease (icd-10 h.81) using traditional medicine and therapeutic interventions: Case report
Undarmaa B ; Tserendulam G ; Oyun-Erdene U ; Oyunnyam Ch ; Nasankhishig D ; Khaliun E ; Tsegmed G ; Oyunbileg Yu ; Enkhtuya V
Mongolian Journal of Health Sciences 2025;87(3):72-74
Background:
Meniere's disease is a condition caused by disturbances in the
auditory and vestibular systems. It is characterized by symptoms such as dizziness,
nausea, vomiting, and tinnitus. In the United States, the prevalence of
Meniere's disease has been found to be 84 cases per 100,000 women and
56 cases per 100,000 men. Regionally, it is more common in less populated
areas, and research has confirmed that the prevalence increases with higher
household income.
Aim:
To evaluate the effectiveness of traditional medicine treatments and therapies
for Meniere's disease.
Results:
The patient is a 43-year-old male, with symptoms of dizziness, vomiting,
and tinnitus. Since 2023, he has sought care at the Central Hospital of
Mongolian Medicine, where he received traditional medicine treatments including
herbal therapy and other traditional therapies on three occasions. As a
result, the frequency of dizziness has decreased and other clinical symptoms
have improved.
Conclusion
Traditional medicine treatments have been shown to be effective
in managing Meniere's disease by extending the interval between relapses,
improving quality of life, and significantly reducing clinical symptoms.
7.Analysis of Mandibular Fracture Cases Recorded in Mongolia
Gantsetseg G ; Ganbaatar Yu ; Batbold G ; Nyamtseren D ; Ochbayar N ; Davaakhuu Sh ; Enkh-Orchlon B
Mongolian Journal of Health Sciences 2025;86(2):77-83
Background:
The craniofacial region is one of the most frequently injured parts of the human body, with mandibular
fractures being the most common type of facial skeletal injury. The leading causes of mandibular fractures include traffic
accidents, falls, interpersonal violence, and sports-related injuries. In Mongolia, mandibular fractures are prevalent, with
a higher incidence among males. However, to date, no national-level analysis of mandibular fractures has been conducted.
This study aims to comprehensively examine mandibular fractures in Mongolia by identifying demographic factors and
causes of injury.
Aim:
To determine the incidence and causes of mandibular fractures recorded in Mongolia over the past ten years.
Materials and Methods:
This study collected data on mandibular fractures recorded in the Health Development Center
of Mongolia between 2014 and 2023. Cases were identified using the International Classification of Diseases (ICD-10)
code S02.6. Information on patient age, gender, and hospital diagnosis was collected, along with the cause of injury, classified
according to ICD-10 codes. Patient age was categorized based on the classification system of the National Statistics
Office. Statistical analysis was performed using SPSS 26.00 software, employing the chi-square test for data analysis.
Results:
During the study period, a total of 2,872 patients were diagnosed with mandibular fractures, with the highest
incidence occurring in the 20-40 age group. The average patient age was 31.1±12 years. Males were 5.6 times more likely
to sustain mandibular fractures compared to females. The primary causes of injury were interpersonal violence (42%),
mechanical trauma (17%), falls (16%), and traffic accidents (15%).
Conclusion
Between 2014 and 2023, 2,872 cases of mandibular fractures were recorded in Mongolia, with the majority
occurring in individuals aged 20-40 years. The leading causes of mandibular fractures were interpersonal violence, mechanical
trauma, falls, and traffic accidents. Specialized trauma care services were accessed differently in urban and rural
areas.
8.Some digestive system disorders affecting factors
Chantsaldulam G ; Baasandorj Yu ; Baasanjargal N ; Zandarmaa Kh ; Oyuntsetseg D
Diagnosis 2025;113(2):40-44
Introduction:
According to epidemiological studies conducted in Mongolia over the past decade, diseases of the digestive system have consistently ranked second in terms of morbidity and fourth in mortality. With the rapid advancement of technology, sedentary lifestyles and unhealthy living habits have become more prevalent among the population, leading to a trend of digestive disorders affecting younger age groups. Therefore, investigating the prevalence, pathological changes, and risk factors associated with gallbladder and pancreatic diseases among university students has become the rationale for this study.
Objective:
To study the prevalence of gallbladder and pancreatic disorders and determine some of the associated risk factors.
Methodology:
200 students from the first to sixth year were selected through random sampling based on the WHO age classification. Data collection included a structured questionnaire and ultrasound examination using the SUN-800D device. Diagnostic criteria followed the national clinical guidelines for acute cholecystitis.
Results:
Out of 200 participants, 120 (60%) were female and 80 (40%) were male. Among them, 128 students (64%) reported skipping breakfast regularly, and 147 (73.5%) did not consume an adequate amount of fluids daily. Ultrasound examinations revealed that 104 students (52%) had some form of gallbladder or pancreatic abnormality. Additionally, gallstones were detected in 1 student (0.5%), and gallbladder polyps were found in 5 students (2.5%).
Conclusion
Gallbladder and pancreatic abnormalities were observed in 52% of the participants. Among the associated risk factors, 64% of students reported skipping breakfast, and 73.5% had inadequate daily fluid intake. The ultrasound findings showed that 47% had biliary sludge, 32% had gallbladder kinking, and 48.5% had increased pancreatic echogenicity.
9.A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignancies.
Lijun ZHAO ; Shuhong LI ; Xiaoyi WEI ; Xuexiu QI ; Qiaoru GUO ; Licai SHI ; Ji-Shuai ZHANG ; Jun LI ; Ze-Lin LIU ; Zhi GUO ; Hongyu ZHANG ; Jia FENG ; Yuanyuan SHI ; Suping ZHANG ; Yu J CAO
Protein & Cell 2025;16(3):227-231
10.The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility.
Xiaoting HOU ; Yu CHEN ; Bo ZHOU ; Fengting LIU ; Lingyun DAI ; Chunbo CHEN ; Noah D CARRILLO ; Vincent L CRYNS ; Richard A ANDERSON ; Jichao SUN ; Mo CHEN
Protein & Cell 2025;16(10):840-857
Dysregulation of p53 and phosphoinositide (PIPn) signaling are both key drivers of oncogenesis and metastasis. Our recent findings reveal a previously unrecognized interaction between these pathways, converging in the nucleus to form a PIPn-p53 signalosome that modulates nuclear AKT activation and downstream signaling, thereby influencing cancer cell survival and motility. This review examines recent insights into nuclear PIPn signaling in the context of established roles for p53 in cell dynamics and migration while also deliberating current research on how nuclear PIPns interact with p53 to form signalosomes that affect cell motility. We emphasize the critical role of PIPns in stabilizing p53 and activating de novo nuclear AKT signaling, which subsequently modulates key motility-related pathways. Understanding the unique operation and function of the PIPn-p53 signalosome in nuclear phosphatidylinositol 3-kinase (PI3K)-AKT activation offers novel therapeutic strategies for controlling cancer metastasis by targeting pertinent interactions and events.
Humans
;
Tumor Suppressor Protein p53/metabolism*
;
Signal Transduction
;
Cell Movement
;
Cell Nucleus/metabolism*
;
Phosphatidylinositols/metabolism*
;
Proto-Oncogene Proteins c-akt/metabolism*
;
Animals
;
Neoplasms/pathology*
;
Phosphatidylinositol 3-Kinases/metabolism*

Result Analysis
Print
Save
E-mail